Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Levofloxacin for chronic prostatitis has completed, and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levaquin (levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Prostatitis | Phase 3 | Status: COMPLETED | Results posted: 2009-07-16